A single-molecule force spectroscopy nanosensor for the identification of new antibiotics and antimalarials.
An important goal of nanotechnology is the application of individual molecule handling techniques to the discovery of potential new therapeutic agents. Of particular interest is the search for new inhibitors of metabolic routes exclusive of human pathogens, such as the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathway essential for the viability of most human pathogenic bacteria and of the malaria parasite. Using atomic force microscopy single-molecule force spectroscopy (SMFS), we have probed at the single-molecule level the interaction of 1-deoxy-D-xylulose 5-phosphate synthase (DXS), which catalyzes the first step of the MEP pathway, with its two substrates, pyruvate and glyceraldehyde-3-phosphate. The data obtained in this pioneering SMFS analysis of a bisubstrate enzymatic reaction illustrate the substrate sequentiality in DXS activity and allow for the calculation of catalytic parameters with single-molecule resolution. The DXS inhibitor fluoropyruvate has been detected in our SMFS competition experiments at a concentration of 10 μM, improving by 2 orders of magnitude the sensitivity of conventional enzyme activity assays. The binding of DXS to pyruvate is a 2-step process with dissociation constants of k(off) = 6.1 × 10(-4) ± 7.5 × 10(-3) and 1.3 × 10(-2) ± 1.0 × 10(-2) s(-1), and reaction lengths of x(β) = 3.98 ± 0.33 and 0.52 ± 0.23 Å. These results constitute the first quantitative report on the use of nanotechnology for the biodiscovery of new antimalarial enzyme inhibitors and open the field for the identification of compounds represented only by a few dozens of molecules in the sensor chamber.
Sisquella
Xavier
X
Nanotechnology Platform, Barcelona Science Park, Barcelona, Spain.
de Pourcq
Karel
K
Alguacil
Javier
J
Robles
Jordi
J
Sanz
Fausto
F
Anselmetti
Dario
D
Imperial
Santiago
S
Fernàndez-Busquets
Xavier
X
D000900:Anti-Bacterial Agents / Q000032:analysis* / Q000737:chemistry; D000962:Antimalarials / Q000032:analysis* / Q000737:chemistry; D015374:Biosensing Techniques / Q000295:instrumentation* / Q000379:methods; D055808:Drug Discovery / Q000295:instrumentation / Q000379:methods; D004800:Enzymes, Immobilized; D004926:Escherichia coli / Q000235:genetics; D006801:Humans; D015394:Molecular Structure; D036103:Nanotechnology / Q000295:instrumentation* / Q000379:methods; D012680:Sensitivity and Specificity; D013057:Spectrum Analysis / Q000295:instrumentation* / Q000379:methods; D014166:Transferases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D004800:Enzymes, Immobilized; D014166:Transferases; C109461:deoxyxylulose-5-phosphate synthase